Annual Cash & Cash Equivalents:
$124.29M-$19.45M(-13.53%)Summary
- As of today, RLAY annual cash & cash equivalents is $124.29 million, with the most recent change of -$19.45 million (-13.53%) on December 31, 2024.
- During the last 3 years, RLAY annual cash & cash equivalents has fallen by -$155.83 million (-55.63%).
- RLAY annual cash & cash equivalents is now -72.24% below its all-time high of $447.65 million, reached on December 31, 2020.
Performance
RLAY Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$596.43M-$60.34M(-9.19%)Summary
- As of today, RLAY quarterly cash & cash equivalents is $596.43 million, with the most recent change of -$60.34 million (-9.19%) on September 30, 2025.
- Over the past year, RLAY quarterly cash & cash equivalents has dropped by -$243.18 million (-28.96%).
- RLAY quarterly cash & cash equivalents is now -43.40% below its all-time high of $1.05 billion, reached on September 30, 2022.
Performance
RLAY Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RLAY Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -13.5% | -29.0% |
| 3Y3 Years | -55.6% | -43.4% |
| 5Y5 Years | +196.3% | -16.4% |
RLAY Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -55.6% | at low | -43.4% | at low |
| 5Y | 5-Year | -72.2% | +196.3% | -43.4% | at low |
| All-Time | All-Time | -72.2% | +196.3% | -43.4% | +91.0% |
RLAY Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $596.43M(-9.2%) |
| Jun 2025 | - | $656.77M(-7.5%) |
| Mar 2025 | - | $710.36M(-9.1%) |
| Dec 2024 | $124.29M(-13.5%) | $781.32M(-6.9%) |
| Sep 2024 | - | $839.61M(+22.0%) |
| Jun 2024 | - | $688.41M(-8.2%) |
| Mar 2024 | - | $749.61M(-0.1%) |
| Dec 2023 | $143.74M(-5.3%) | $750.09M(-7.5%) |
| Sep 2023 | - | $810.62M(-7.0%) |
| Jun 2023 | - | $871.57M(-7.1%) |
| Mar 2023 | - | $937.80M(-6.1%) |
| Dec 2022 | $151.79M | $998.92M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.05B(+25.8%) |
| Jun 2022 | - | $837.99M(-6.7%) |
| Mar 2022 | - | $898.18M(-6.3%) |
| Dec 2021 | $280.12M(-37.4%) | $958.07M(+55.4%) |
| Sep 2021 | - | $616.51M(-8.2%) |
| Jun 2021 | - | $671.22M(-7.6%) |
| Mar 2021 | - | $726.08M(+7.1%) |
| Dec 2020 | $447.65M(+967.0%) | $678.06M(-5.0%) |
| Sep 2020 | - | $713.47M(+128.5%) |
| Jun 2020 | - | $312.21M(-6.6%) |
| Mar 2020 | - | $334.20M(-6.1%) |
| Dec 2019 | $41.95M(-90.0%) | $355.82M |
| Dec 2018 | $421.50M | - |
FAQ
- What is Relay Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Relay Therapeutics, Inc.?
- What is Relay Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Relay Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Relay Therapeutics, Inc.?
- What is Relay Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Relay Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of RLAY is $124.29M
What is the all-time high annual cash & cash equivalents for Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. all-time high annual cash & cash equivalents is $447.65M
What is Relay Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, RLAY annual cash & cash equivalents has changed by -$19.45M (-13.53%)
What is Relay Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RLAY is $596.43M
What is the all-time high quarterly cash & cash equivalents for Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $1.05B
What is Relay Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, RLAY quarterly cash & cash equivalents has changed by -$243.18M (-28.96%)